[1] Schlupf J, Steinbeisser H. IGF antagonizes the Wnt/β-Catenin pathway and promotes differentiation of extra-embryonic endoderm. Differentiation , 2014, 87(5): 209-219. [2] Constância M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley C, Reik W. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature , 2002, 417(6892): 945-948. [3] Wang YM, Nishida S, Sakata T, Elalieh HZ, Chang WH, Halloran BP, Doty SB, Bikle DD. Insulin-like growth factor-I is essential for embryonic bone development. Endocrinology , 2006, 147(10): 4753-4761. [4] Chen L, Jiang W, Huang JY, He BC, Zuo GW, Zhang WL, Luo Q, Shi Q, Zhang BQ, Wagner ER, Luo JY, Tang M, Wietholt C, Luo XJ, Bi Y, Su YX, Liu B, Kim SH, He CJ, Hu YW, Shen JK, Rastegar F, Huang EY, Gao YH, Gao JL, Zhou JZ, Reid RR, Luu HH, Haydon RC, He TC, Deng ZL. Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res , 2010, 25(11): 2447-2459. [5] Ibrahim YH, Yee D. Insulin-like growth factor-I and cancer risk. Growth Horm IGF Res , 2004, 14(4): 261-269. [6] Ren J, Anversa P. The insulin-like growth factor I system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome. Biochem Pharmacol , 2015, 93(4): 409-417. [7] Guler HP, Zapf J, Schmid C, Froesch ER. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh) , 1989, 121(6): 753-758. [8] Zapf J. Insulinlike growth factor binding proteins and tumor hypoglycemia. Trends Endocrinol Met , 1995, 6(2): 37-42. [9] Leong SR, Baxter RC, Camerato T, Dai J, Wood WI. Structure and functional expression of the acid-labile subunit of the insulin-like growth factor-binding protein complex. Mol Endocrinol , 1992, 6(6): 870-876. [10] Boisclair YR, Rhoads RP, Ueki I, Wang J, Ooi GT. The acid-labile subunit (ALS) of the 150 kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system. J Endocrinol , 2001, 170(1): 63-70. [11] Dai J, Baxter RC. Molecular cloning of the acid-labile subunit of the rat insulin-like growth factor binding protein complex. Biochem Biophys Res Commun , 1992, 188(1): 304-309. [12] Boisclair YR, Seto D, Hsieh S, Hurst KR, Ooi GT. Organization and chromosomal localization of the gene encoding the mouse acid labile subunit of the insulin-like growth factor binding complex. Proc Natl Acad Sci USA , 1996, 93(19): 10028-10033. [13] Rhoads RP, Greenwood PL, Bell AW, Boisclair YR. Organization and regulation of the gene encoding the sheep acid-labile subunit of the 150-kilodalton insulin-like growth factor-binding protein complex. Endocrinology , 2000, 141(4): 1425-1433. [14] Li S, Ren JF, Huang L. Characterization of the porcine insulin- like growth factor-binding protein , acid-labile subunit gene: full-length cDNA and DNA sequence, polymorphisms and expression profile. J Anim Breed Genet , 2007, 124(3): 133-138. [15] Kim JW, Rhoads RP, Segoale N, Kristensen NB, Bauman DE, Boiselair YR. Isolation of the cDNA encoding the acid labile subunit (ALS) of the 150 kDa IGF-binding protein complex in cattle and ALS regulation during the transition from pregnancy to lactation. J Endocrinol , 2006, 189(3): 583-593. [16] Lee DH, Chun C, Kim SH, Lee CY. Expression of porcine acid-labile subunit (pALS) of the 150-kilodalton ternary insulin-like growth factor complex and initial characterization of recombinant pALS protein. J Biochem Mol Biol , 2005, 38(2): 225-231. [17] Janosi JB, Firth SM, Bond JJ, Baxter RC, Delhanty PJ. N-Linked glycosylation and sialylation of the acid-labile subunit. Role in complex formation with insulin-like growth factor (IGF)-binding protein-3 and the IGFs. J Biol Chem , 1999, 274(9): 5292-5298. [18] Baxter RC, Martin JL, Beniac VA. H |